William Pridgen, Director at Virios Therapeutics, Inc. (VIRI), bought 15,335 shares at $1.30 ($20K) on 2023-08-21, disclosed to the SEC on 2023-08-22.
Open-market purchase of $20k VIRI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| VIRI | BUY | 2022-03-30 | $3K | — | Filing → |
| VIRI | BUY | 2022-03-24 | $12K | — | Filing → |
| VIRI | BUY | 2022-01-28 | $25K | — | Filing → |